http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000355543-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fbe0bc11207551c2580fe57cd9e0915 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate | 1999-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c24378c61ec1a95da6908e77c02376 |
publicationDate | 2000-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000355543-A |
titleOfInvention | Aspirin-based topical treatment for tinea unguium |
abstract | (57) [Summary] [Purpose] A drug that is safe and has a high curative effect on tinea unguium has been long-awaited. The present invention has been completed by discovering an unknown use in which a drug obtained by dissolving aspirin in polyethylene glycol has a great healing effect on tinea unguium. [Effect] 5% of aspirin in polyethylene glycol Dissolve at a rate of 10% or add benzoic acid or salicylic acid to enhance the healing effect, and to the affected area of tinea unguium ~ 2 weeks of use leads to healing. There are no safety issues. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526727-A |
priorityDate | 1999-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.